Skip to main content
Smart Investors Daily
AL

NASDAQ · ALC

Alcon Inc.

Healthcare · Medical - Instruments & Supplies

$74.31

Down-$0.19 (-0.26%)

Updated Nov 22, 2026, 4:26 PM

SID Score

6.2/10

Composite research score

Smart Money

48/100

Neutral

Market cap
42.99B
P/E ratio
43.53
Dividend yield
0.45%
52-week range
$61.84 – $87.64
Volume
3.42M
Avg. volume
1.54M

Price performance · ALC

ALC price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 20, 2026

ALC closed at $74.31 after 20 trading sessions, up 6.17% for the selected period.

Last close
$74.31
Period change
+6.17%
Period low
$69.42
Period high
$77.31
Daily close
View OHLC price history
ALC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 20, 2026$74.165$75.04$74.10$74.313.42M
Nov 19, 2026$74.80$75.92$74.45$74.503.96M
Nov 18, 2026$73.41$75.52$73.34$75.264.77M
Nov 17, 2026$73.405$74.54$73.36$74.114.8M
Nov 16, 2026$74.35$74.76$73.495$73.641.77M
Nov 13, 2026$72.97$74.18$72.575$74.122.79M
Nov 12, 2026$73.06$73.955$71.64$71.832.25M
Nov 11, 2026$71.70$72.535$70.34$72.464.87M
Nov 10, 2026$74.72$75.705$72.21$74.065.33M
Nov 9, 2026$74.62$75.49$74.28$75.142.82M
Nov 6, 2026$74.24$75.23$74.01$74.943.17M
Nov 5, 2026$77.17$77.825$76.185$76.552.63M
Nov 4, 2026$75.70$77.85$75.58$77.313.75M
Nov 3, 2026$73.04$73.24$72.345$72.371.92M
Nov 2, 2026$72.06$74.19$72.03$73.632.2M
Oct 30, 2026$72.34$72.715$71.27$71.451.61M
Oct 29, 2026$70.44$71.35$70.39$71.131.26M
Oct 28, 2026$68.875$70.08$68.82$69.831.09M
Oct 27, 2026$69.58$70.02$69.30$69.421.2M
Oct 26, 2026$70.08$70.45$69.70$69.991.46M

Latest ALC news

The latest Smart Investors Daily articles mentioning ALC.

ALC research

Overview

Company profile and research snapshot.

Company profile

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$92.35
Implied upside
—
Analysts
6
ALC recent ratings
DateFirmRatingTarget
Sep 21, 2026BERENBERGBuy—
Aug 31, 2026BNP PARIBASNeutral—
Aug 14, 2026EQUITA SIMBuy—
Aug 11, 2026NEEDHAM & COMPANY INC.Buy—
Jul 20, 2026DAY BY DAYSell—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 20, 2026

Alcidion Group (ASX:ALC) Shares Fair Value Rises After MedTech Analysts Reassess Valuations

Alcidion Group’s narrative fair value has been reset sharply, moving from A$0.15 per share to A$1.48 per share as analysts update their price targets. That step change sits alongside broader MedTech commentary, where research houses are reassessing valuation frameworks, risk premiums and growth assumptions across the sector. As you read on, you will see how this new A$1.48 reference point fits into the evolving story around Alcidion Group and what to watch as the narrative continues to...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.